Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Update

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) saw a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 52,840 shares, a growth of 391.6% from the April 15th total of 10,749 shares. Based on an average daily trading volume, of 48,017 shares, the days-to-cover ratio is presently 1.1 days. Currently, 16.0% of the company’s shares are sold short.

Defiance Daily Target 2X Long LMND ETF Trading Down 6.0%

Shares of LMNX traded down $0.72 during trading on Friday, reaching $11.34. 8,927 shares of the company traded hands, compared to its average volume of 47,374. Defiance Daily Target 2X Long LMND ETF has a twelve month low of $10.94 and a twelve month high of $55.00. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52. The stock has a 50-day simple moving average of $16.70 and a 200-day simple moving average of $26.78. The stock has a market cap of $3.74 million, a PE ratio of 22.24 and a beta of -10.46.

About Defiance Daily Target 2X Long LMND ETF

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.